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Objective:  
Congenital cytomegalovirus (CMV) is 
the most common cause of congenital-
acquired infection in the United States 
and preterm birth continues to be a 
world-wide public health problem.  
Given infection has been shown to play 
a role in preterm delivery; the objective 
of this study was to determine the 
prevalence of congenital CMV infection 
in a population of preterm infants and 
determine if it a risk factor for preterm 
birth.   
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Methods:   
DNA was extracted from biologic 
samples (blood, saliva, buccal swabs) of 
preterm infants and multiplex PCR using 
primers and conditions optimized from 
previous studies was performed to 
detect CMV nucleic acids from human 
DNA.  Chi-square and Fischer tests 
were used for statistical analysis.   
Results:   
Of the 1,200 premature infants tested, 
37 tested positive for CMV (3.08%). This 
finding is significantly higher than the 
0.48% infection rate observed in term 
infants from Iowa (p=<0.001), significant 
(P=1.7x10-9) difference by sample type 
with all of the CMV+ samples coming 
from buccal swabs. Comparing our rate 
among buccal swabs only to the 
published rate in buccal swabs from 
term infants we find there is a 
significantly higher rate in preterm 
infants (P=4.1x10-9). 
Conclusion:   
This is largest study to date 
investigating the potential association 
between congenital CMV infection and 
preterm birth in a primarily Caucasian 
population.   Given the higher rate of 
congenital CMV in our study, this 
demonstrates the need for a CMV 
screening program, and our results 
suggest that a main target population of 
such a program should be preterm 
infants.  Buccal swabs may be the ideal 
sample type to use for screening 
purposes.   
